Multi-ancestry MHC-pQTL mapping reveals disease-linked HLA protein networks and shared genetic architecture

The human body is a vast network of chemical signals, where proteins act as messengers, workers, and structural beams that keep our systems running. These proteins circulate in our blood, and their levels are not random; they are heavily influenced by the unique blueprint of our DNA. One specific region of our genetic code, known as the major histocompatibility complex, is particularly crowded and complex. It contains a set of genes that act as the immune system's identification cards, helping our bodies distinguish between our own cells and foreign invaders like viruses. Because this region is so intricate and varies so wildly from person to person, scientists have long struggled to understand exactly how differences in these genes ripple out to change the levels of proteins in our blood. Understanding this connection is crucial because it could explain why certain people are more susceptible to autoimmune diseases, where the immune system mistakenly attacks the body, or why they respond differently to infections.

A team of researchers from the University of Oxford and Peking University has now taken a significant step toward solving this puzzle by looking at the genetic blueprints and blood samples of thousands of people from two very different parts of the world. They studied nearly 44,000 individuals of European ancestry from the UK Biobank and nearly 4,000 individuals of East Asian ancestry from the China Kadoorie Biobank. By analyzing the blood of these participants, they measured the levels of nearly 3,000 different proteins. They then cross-referenced these protein levels with the specific variations in the major histocompatibility complex region of their DNA. This approach allowed them to map out how genetic differences in this specific area of the genome shape the entire landscape of circulating proteins in the blood.

The study revealed that the genetic variations in this immune region act like a master switch, influencing the abundance of hundreds of proteins far away from the genes themselves. Out of the nearly 3,000 proteins they tested, they found significant links to 619 of them. The vast majority of these connections were not local; instead, a change in one part of the immune gene region caused a shift in the levels of proteins produced by completely different genes elsewhere in the body. This suggests that the immune system's identification cards do more than just tag cells; they orchestrate a wide-ranging chemical conversation throughout the entire body. The researchers also found that these genetic effects were remarkably consistent between the European and East Asian groups, indicating that this fundamental biological wiring is shared across human populations. However, the inclusion of the East Asian cohort was essential, as it uncovered a unique genetic link that was invisible in the European group alone.

One of the most striking discoveries was how the immune system's two main branches, known as class I and class II, organize these protein networks differently. The researchers found that variations in the class I genes primarily influenced proteins involved in direct cellular attacks and inflammation, such as those used by natural killer cells to destroy infected tissue. In contrast, variations in the class II genes were linked to proteins that facilitate communication and movement, helping immune cells migrate and talk to one another. This separation shows that the two branches of the immune system, while working together, drive distinct downstream programs that shape the body's chemical environment in specific ways.

To understand how these protein networks relate to actual disease, the team looked at the genetic signals for multiple sclerosis, a condition where the immune system attacks the nervous system, and for antibody responses to the Epstein-Barr virus, a common virus that causes mononucleosis. They discovered that the same genetic variations in the immune region that influenced protein levels were also the ones driving the risk for multiple sclerosis. A particularly clear example involved a protein called beta-2-microglobulin, which is a structural partner to the immune identification cards. The study showed that the genetic variant that protects against multiple sclerosis also strongly influences the levels of this protein, suggesting that the disease risk is mediated through this specific protein network rather than a single isolated factor. Similarly, the genetic signals for the immune response to the active phase of the Epstein-Barr virus were linked to a broader network of proteins than the response to the dormant phase, hinting that the body's reaction to an active infection involves a more complex chemical cascade.

The power of studying diverse populations became evident when the researchers examined a protein called EDAR, which is involved in the development of hair, teeth, and sweat glands. In the East Asian group, a specific variant of an immune gene was strongly linked to higher levels of this protein in the blood. This same link was not detectable in the European group, largely because the genetic variant is much rarer in that population. This finding highlights that relying on a single population can miss biologically important connections that are common in other parts of the world. It also underscores how the immune system's genetic machinery can influence traits that seem unrelated to immunity, such as the development of skin and hair.

Ultimately, this research provides a detailed map of how the most complex and disease-relevant part of our genome controls the chemical signals in our blood. It moves beyond simply listing genetic associations to showing how these variations organize into coherent networks that drive immune function and disease risk. By confirming that these networks are largely shared across different human groups while also identifying unique, population-specific signals, the study offers a more complete picture of human biology. It suggests that to fully understand why people get sick or how their bodies respond to threats, we must look at the entire system of proteins influenced by our genes, rather than focusing on single genes in isolation. This work lays the groundwork for future studies to explore how these protein networks can be targeted to treat immune-related diseases, ensuring that medical advances benefit people of all ancestral backgrounds.